L’Oréal sales
This article was originally published in The Rose Sheet
Executive Summary
North American cosmetics sales increase 14% to $3.75 bil. (€1=$.88) in 2001 including currency effects, French firm reports Jan. 23. Sales in Western Europe were up 5.6%, while sales in the rest of the world rose 8.8%. Consolidated sales reached $12.06 bil., representing an increase of 8.4% over the prior year. L'Oréal acquired Biomedic skin care and Colorama makeup in 2001 (11"The Rose Sheet" May 14, 2001, p. 6 and 22"The Rose Sheet" July 9, 2001, In Brief)...
You may also be interested in...
L’Oréal earnings
Profit before capital gains and losses and after minority interests jumps 19.6% to $1.07 bil. (€1=$.87) in 2001, L'Oréal says in 1Feb. 22 announcement. Growth is attributed to "brand-related initiatives" combined with strong sales in international markets such as China, where sales grew by 26% and Russia, where sales increased 52%, the French beauty marketer adds. During the year, product initiatives, such as Garnier Lumia hair color and Lancôme Absolue skin care successfully targeted new consumers, the company notes. Matrix, Carson and Kiehl's brands, acquired in 2000, produced sales of $455.3 mil. in 2001. L'Oreal released 2001 consolidated sales of $12.06 bil., up 8.4%, in January (2"The Rose Sheet" Jan. 28, 2002, In Brief)...
Revlon
Colorama cosmetics and hair care products sold to L'Oreal for $55 mil. in effort to focus on core brands, Revlon says. Sale includes nail enamel, lip color, shampoo and conditioners sold primarily in Brazil, as well as manufacturing facility in Sao Paulo, firm says. Transaction is expected to close in July. Revlon will continue to market Bozzano and Juveno businesses in Brazil. All three brands were targeted for divestiture, along with Argentinian hair care brand Plusbelle and Revlon's professional portfolio, in 1999 (1"The Rose Sheet" Oct. 4, 1999, p. 4). Plusbelle was sold to Dial for $46.5 mil. and professional business was divested to Colomer Group for $315 mil. in 2000
L'Oreal BioMedic Purchase To Expand Skin Care Sales Through MDs
The acquisition of Phoenix, Ariz.-based BioMedic by L'Oreal USA will increase the cosmetic giant's currently limited U.S. presence in direct-to-physician skin care product sales as well as continue to build the company's global portfolio of "dermocosmetics," L'Oreal said. Announced May 9, the transaction is expected to close in the next two months.